Genetic disorders of mitochondrial fatty acid oxidation

C. A. Stanley, D. E. Hale

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Genetic diseases of mitochondrial fatty acid oxidation have recently emerged as important disorders to consider in the differential diagnosis of hypoglycemia, cardiomyopathy, or skeletal muscle weakness in infants and children. A total of 16 different defects have been identified over the past decade that involve almost all of the possible enzyme steps in the pathway. One of these disorders, medium-chain acyl-coenzyme A dehydrogenase deficiency has a frequency as high as 1 in 10,000 births and is the single most common genetic defect of intermediary metabolism. The disorders are frequently mistaken for Reye syndrome or sudden infant death syndrome. Improved methods have simplified the diagnosis of some of the fatty acid oxidation defects. However, recognition of these disorders remains challenging. Rapid advances have continued to be made over the past year in defining clinical phenotypes, diagnostic methods, and therapeutic strategies. Familiarity with this new group of disorders is becoming increasingly important for general pediatricians as well as subspecialists in metabolism, endocrinology, gastroenterology, cardiology, neurology, and genetics.

Original languageEnglish (US)
Pages (from-to)476-481
Number of pages6
JournalCurrent Opinion in Pediatrics
Volume6
Issue number4
StatePublished - 1994
Externally publishedYes

Fingerprint

Inborn Genetic Diseases
Fatty Acids
Reye Syndrome
Sudden Infant Death
Endocrinology
Muscle Weakness
Gastroenterology
Neurology
Cardiology
Cardiomyopathies
Hypoglycemia
Skeletal Muscle
Differential Diagnosis
Parturition
Phenotype
Enzymes
Recognition (Psychology)
Therapeutics
Pediatricians
Medium chain acyl CoA dehydrogenase deficiency

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Stanley, C. A., & Hale, D. E. (1994). Genetic disorders of mitochondrial fatty acid oxidation. Current Opinion in Pediatrics, 6(4), 476-481.

Genetic disorders of mitochondrial fatty acid oxidation. / Stanley, C. A.; Hale, D. E.

In: Current Opinion in Pediatrics, Vol. 6, No. 4, 1994, p. 476-481.

Research output: Contribution to journalArticle

Stanley, CA & Hale, DE 1994, 'Genetic disorders of mitochondrial fatty acid oxidation', Current Opinion in Pediatrics, vol. 6, no. 4, pp. 476-481.
Stanley, C. A. ; Hale, D. E. / Genetic disorders of mitochondrial fatty acid oxidation. In: Current Opinion in Pediatrics. 1994 ; Vol. 6, No. 4. pp. 476-481.
@article{1f631399a71a4391b73ac80feb570f1e,
title = "Genetic disorders of mitochondrial fatty acid oxidation",
abstract = "Genetic diseases of mitochondrial fatty acid oxidation have recently emerged as important disorders to consider in the differential diagnosis of hypoglycemia, cardiomyopathy, or skeletal muscle weakness in infants and children. A total of 16 different defects have been identified over the past decade that involve almost all of the possible enzyme steps in the pathway. One of these disorders, medium-chain acyl-coenzyme A dehydrogenase deficiency has a frequency as high as 1 in 10,000 births and is the single most common genetic defect of intermediary metabolism. The disorders are frequently mistaken for Reye syndrome or sudden infant death syndrome. Improved methods have simplified the diagnosis of some of the fatty acid oxidation defects. However, recognition of these disorders remains challenging. Rapid advances have continued to be made over the past year in defining clinical phenotypes, diagnostic methods, and therapeutic strategies. Familiarity with this new group of disorders is becoming increasingly important for general pediatricians as well as subspecialists in metabolism, endocrinology, gastroenterology, cardiology, neurology, and genetics.",
author = "Stanley, {C. A.} and Hale, {D. E.}",
year = "1994",
language = "English (US)",
volume = "6",
pages = "476--481",
journal = "Current Opinion in Pediatrics",
issn = "1040-8703",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Genetic disorders of mitochondrial fatty acid oxidation

AU - Stanley, C. A.

AU - Hale, D. E.

PY - 1994

Y1 - 1994

N2 - Genetic diseases of mitochondrial fatty acid oxidation have recently emerged as important disorders to consider in the differential diagnosis of hypoglycemia, cardiomyopathy, or skeletal muscle weakness in infants and children. A total of 16 different defects have been identified over the past decade that involve almost all of the possible enzyme steps in the pathway. One of these disorders, medium-chain acyl-coenzyme A dehydrogenase deficiency has a frequency as high as 1 in 10,000 births and is the single most common genetic defect of intermediary metabolism. The disorders are frequently mistaken for Reye syndrome or sudden infant death syndrome. Improved methods have simplified the diagnosis of some of the fatty acid oxidation defects. However, recognition of these disorders remains challenging. Rapid advances have continued to be made over the past year in defining clinical phenotypes, diagnostic methods, and therapeutic strategies. Familiarity with this new group of disorders is becoming increasingly important for general pediatricians as well as subspecialists in metabolism, endocrinology, gastroenterology, cardiology, neurology, and genetics.

AB - Genetic diseases of mitochondrial fatty acid oxidation have recently emerged as important disorders to consider in the differential diagnosis of hypoglycemia, cardiomyopathy, or skeletal muscle weakness in infants and children. A total of 16 different defects have been identified over the past decade that involve almost all of the possible enzyme steps in the pathway. One of these disorders, medium-chain acyl-coenzyme A dehydrogenase deficiency has a frequency as high as 1 in 10,000 births and is the single most common genetic defect of intermediary metabolism. The disorders are frequently mistaken for Reye syndrome or sudden infant death syndrome. Improved methods have simplified the diagnosis of some of the fatty acid oxidation defects. However, recognition of these disorders remains challenging. Rapid advances have continued to be made over the past year in defining clinical phenotypes, diagnostic methods, and therapeutic strategies. Familiarity with this new group of disorders is becoming increasingly important for general pediatricians as well as subspecialists in metabolism, endocrinology, gastroenterology, cardiology, neurology, and genetics.

UR - http://www.scopus.com/inward/record.url?scp=0028040626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028040626&partnerID=8YFLogxK

M3 - Article

C2 - 7951672

AN - SCOPUS:0028040626

VL - 6

SP - 476

EP - 481

JO - Current Opinion in Pediatrics

JF - Current Opinion in Pediatrics

SN - 1040-8703

IS - 4

ER -